Trial Profile
Prospective study of efficacy and safety of preoperative transcatheter arterial chemolipiodolization with miriplatin for hepatocellular carcinoma.(Phase II study)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 05 Mar 2014 New trial record